What is NDC 42571-205?

42571-205 is the product NDC for OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE, Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, film coated, listed with the FDA by Micro Labs Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE.

What is the active ingredient?

Olmesartan medoxomil, Hydrochlorothiazide.

Micro Labs Limited, NDC labeler code 42571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

NDC 42571-205

NDC codes

FDA NDC Directory

Product NDC (as listed)42571-205Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42571-0205Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42571-205-05	4257102050542571020505	500 TABLET, FILM COATED in 1 BOTTLE (42571-205-05)Marketed from Oct 15, 2026
42571-205-10	4257102051042571020510	1000 TABLET, FILM COATED in 1 BOTTLE (42571-205-10)Marketed from Oct 15, 2026
42571-205-30	4257102053042571020530	30 TABLET, FILM COATED in 1 BOTTLE (42571-205-30)Marketed from Oct 15, 2026
42571-205-90	4257102059042571020590	90 TABLET, FILM COATED in 1 BOTTLE (42571-205-90)Marketed from Oct 15, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE
Generic name (nonproprietary): olmesartan medoxomil and hydrocholorothiazide
Active ingredients: Olmesartan medoxomil — 40 mg/1Hydrochlorothiazide — 12.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Micro Labs LimitedNDC labeler code 42571
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206371
Marketing start: Oct 15, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 42571-205_4f799eb1-290a-640c-e063-6294a90ac62bSPL ID 4f799eb1-290a-640c-e063-6294a90ac62bSPL set ID 576b315a-4830-42b5-bf5f-76fe4bbc0f8cRxCUI 403853, 403854, 403855UNII 0J48LPH2TH, 6M97XTV3HDUPC 0342571206307, 0342571205300, 0342571204303
Pharmacologic class: Angiotensin 2 Receptor Blocker; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442571020505 followed by a unit qualifier and the quantity

Package 42571-0205-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 15, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Olmesartan medoxomil and hydrochlorothiazide [HCTZ] tablets are indicated for the treatment of hypertension, to lower blood pressure [see Dosage and Administration (2) ] . Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with olmesartan medoxomil and hydrochlorothiazide tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk managem…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 42571-205

What is NDC 42571-205?: 42571-205 is the product NDC for OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE, Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1 tablet, film coated, listed with the FDA by Micro Labs Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE.
What is the active ingredient?: Olmesartan medoxomil, Hydrochlorothiazide.
Who is the labeler?: Micro Labs Limited, NDC labeler code 42571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 206371

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206371
Product	Strength	Form · route	Labeler	Product NDC
OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE	Olmesartan medoxomil 20 mg/1; Hydrochlorothiazide 12.5 mg/1	Tablet, Film coatedOral	Micro Labs Limited	42571-204
OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE	Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 25 mg/1	Tablet, Film coatedOral	Micro Labs Limited	42571-206

OLMESARTAN MEDOXOMIL and HYDROCHOLOROTHIAZIDE NDC 42571-205